CORC

浏览/检索结果: 共14条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study 期刊论文
2019, 卷号: 37, 期号: 29, 页码: 2610-2619
作者:  Ma Fei;  Ouyang Quchang;  Li Wei;  Jiang Zefei;  Tong Zhongsheng
收藏  |  浏览/下载:33/0  |  提交时间:2020/01/03
Subgroup Analysis for Chinese Patients Included in the INPULSIS (R) Trials on Nintedanib in Idiopathic Pulmonary Fibrosis 期刊论文
2019, 卷号: 36, 期号: 3, 页码: 621-631
作者:  Xu, Zuojun;  Li, Huiping;  Wen, Fuqiang;  Bai, Chunxue;  Chen, Ping
收藏  |  浏览/下载:8/0  |  提交时间:2020/01/03
The etiological effect of a new low-frequency ESR1 variant on Mild Cognitive Impairment and Alzheimer's Disease: a population-based study 期刊论文
2018, 卷号: 10, 期号: 9, 页码: 2316-2337
作者:  Li, Xiaoling;  Zhu, Xiaoquan;  Zhang, Wandong;  Yang, Fan;  Hui, Juan
收藏  |  浏览/下载:18/0  |  提交时间:2020/01/03
AD  MCI  ESR1  cholesterol  A beta  
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载:15/0  |  提交时间:2020/01/03
Identification of new genetic variants of HLA-DQB1 associated with human longevity and lipid homeostasis-a cross-sectional study in a Chinese population (vol 9, pg 2316, 2017) 期刊论文
2018, 卷号: 10, 期号: 3, 页码: 515-515
作者:  Yang, Fan;  Sun, Liang;  Zhu, Xiaoquan;  Han, Jing;  Zeng, Yi
收藏  |  浏览/下载:10/0  |  提交时间:2020/01/03
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/03
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文
2017, 卷号: 18, 期号: 3, 页码: 371-383
作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei
收藏  |  浏览/下载:12/0  |  提交时间:2020/01/04
Identification of new genetic variants of HLA-DQB1 associated with human longevity and lipid homeostasis-a cross-sectional study in a Chinese population 期刊论文
2017, 卷号: 9, 期号: 11, 页码: 2316-2333
作者:  Yang, Fan;  Sun, Liang;  Zhu, Xiaoquan;  Han, Jing;  Zeng, Yi
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/04
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer 期刊论文
2016, 卷号: 16, 页码: 265
作者:  Sun, Yan;  Cheng, Ying;  Hao, Xuezhi;  Wang, Jie;  Hu, Chengping
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 期刊论文
2016, 卷号: 12, 期号: 1, 页码: 1-222
作者:  Klionsky, Daniel J.;  Abdelmohsen, Kotb;  Abe, Akihisa;  Abedin, Md Joynal;  Abeliovich, Hagai
收藏  |  浏览/下载:26/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace